PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial
Abstract
Authors
L. Senolt B.B. Hansen M. Strandberg-Larsen E. Dokoupilová